| 6-months’ follow-up | 15-months’ follow-up | |||||
---|---|---|---|---|---|---|---|
IR | IRR (95% CI) | P | IR | IRR (95% CI) | P | ||
Depression trial | |||||||
 Weeks on sick leave benefit | TAU | 6.1 (3.7–8.5) | 1 |  | 8.8 (4.8–12.7) | 1 |  |
CC | 6.1 (5.0–7.1) | 1.0 (0.7–1.5) | 0.990 | 9.4 (7.8–11.1) | 1.1 (0.7–1.7) | 0.756 | |
 Psychiatric outpatient visits | TAU | 0.5 (0.0–1.1) | 1 |  | 1.4 (0.0–3.0) | 1 |  |
CC | 0.3 (0.2–0.4) | 0.5 (0.2–1.7) | 0.277 | 1.8 (1.1–2.5) | 1.3 (0.4–4.1) | 0.677 | |
 Psychiatric inpatient days | TAU | 0.7 (0.0–1.5) | 1 |  | 0.7 (0.0–1.8) | 1 |  |
CC | 0.1 (0.0–0.1) | 0.1 (0.01–0.7) | 0.019 | 0.2 (0.0–0.6) | 0.4 (0.0–3.4) | 0.373 | |
 Psychiatric admissions | TAU | 0.02 (0.0–0.1) | 1 |  | 0.04 (0.0–0.1) | 1 |  |
CC | 0.01 (0.0–0.03) | 0.8 (0.1–5.5) | 0.781 | 0.03 (0.0–0.1) | 0.6 (0.1–4.2) | 0.645 | |
 Somatic outpatient visits | TAU | 0.4 (0.1–0.8) | 1 |  | 1.7 (0.5–2.9) | 1 |  |
CC | 0.8 (0.6–1.1) | 1.8 (0.7–4.4) | 0.198 | 2.1 (1.5–2.6) | 1.2 (0.6–2.5) | 0.621 | |
Pooled anxiety trial | Â | Â | Â | Â | Â | ||
 Weeks on sick leave benefit | TAU | 1.4 (0.0–3.2) | 1 |  | 2.8 (0.0–5.8) | 1 |  |
CC | 3.4 (2.7–4.1) | 2.4 (0.7–8.7) | 0.189 | 5.6 (4.2–7.0) | 2.0 (0.6–6.4) | 0.236 | |
 Psychiatric outpatient visits | TAU | 0.4 (0.0–0.8) | 1 |  | 1.1 (0.0–2.3) | 1 |  |
CC | 0.2 (0.1–0.3) | 0.5 (0.1–1.5) | 0.201 | 1.4 (0.8–2.0) | 1.3 (0.4–4.4) | 0.663 | |
 Psychiatric inpatient days | TAU | 0.04 (0.0–0.1) | 1 |  | 0.04 (0.0–0.2) | 1 |  |
CC | 0.1 (0.0–0.3) | 2.6 (0.2–43.0) | 0.512 | 0.11 (0.0–0.3) | 2.7 (0.2–44.3) | 0.481 | |
 Psychiatric admissions | TAU | 0.03 (0.0–0.1) | 1 |  | 0.04 (0.0–0.1) | 1 |  |
CC | 0.02 (0.0–0.03) | 0.6 (0.1–5.0) | 0.608 | 0.03 (0.0–0.05) | 0.7 (0.1–7.0) | 0.785 | |
 Somatic outpatient visits | TAU | 0.3 (0.1–0.6) | 1 |  | 1.1 (0.7–1.6) | 1 |  |
CC | 0.6 (0.5–0.7) | 1.7 (0.7–4.1) | 0.213 | 1.8 (1.5–2.1) | 1.6 (1.0–2.5) | 0.052 |